Skip to main content
Equibles
NAMS logo

NAMS · NewAmsterdam Pharma Co N.V. · Short Interest

Track NAMS — free

Use NAMS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NAMS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$21.58 +0.32 (+1.48%) At close · Oct 9
Rebalance outlook locked
Market Cap
$2.58B
Shares
119.54M
Volume · Oct 9 1.27M Avg daily vol (3M) 1.36M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

NAMS Latest Reported Short Interest

FINRA reported 19,045,378 NAMS shares sold short as of the September 30, 2026 settlement date, an increase of 3,384,934 shares. Days to cover was 9.39 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

NAMS Short Interest Forecast

Equibles' model estimates 19,749,095 shares sold short for the October 15, 2026 settlement, +3.7% versus the latest reported position, with a likely range of 17,742,369 to 22,208,918 shares. This model prediction uses FINRA data through October 9, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 9 High confidence 69% chance it rises
19,749,095 +3.7% vs reported
Likely range 17,742,369 to 22,208,918 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
66/100
Short interest 15.9% of shares — P96 Days to cover 9.4 — P90 Price vs VWAP -15.4% — P22 Short-volume trend -13.3% — P14 Short interest change +21.6% — P83 Worst FTD 0.01% of shares — P59

Positioning score 66.3 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-11 16:03 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-10-30 Scheduled
    FINRA publishes Nov 10
    		 — — — —
    2026-10-15 Scheduled
    FINRA publishes Oct 26
    		 — — — —
    2026-09-30 19,045,378 15,660,444 +3,384,934 9.39
    2026-09-15 15,660,444 13,392,021 +2,268,423 9.88
    2026-08-31 13,392,021 12,654,106 +737,915 13.36
    2026-08-14 12,654,106 9,959,761 +2,694,345 9.92
    2026-07-31 9,959,761 9,176,420 +783,341 9.77
    2026-07-15 9,176,420 9,091,198 +85,222 11.20
    2026-06-30 9,091,198 9,171,265 -80,067 6.94
    2026-06-15 9,171,265 8,099,601 +1,071,664 7.30
    2026-05-29 8,099,601 7,139,696 +959,905 6.15
    2026-05-15 7,139,696 7,882,443 -742,747 3.72
    2026-04-30 7,882,443 7,682,586 +199,857 8.94
    2026-04-15 7,682,586 8,047,048 -364,462 8.74
    2026-03-31 8,047,048 7,545,738 +501,310 9.63
    2026-03-13 7,545,738 7,658,931 -113,193 7.33
    2026-02-27 7,658,931 6,951,469 +707,462 11.27
    2026-02-13 6,951,469 7,100,900 -149,431 10.67
    2026-01-30 7,100,900 6,319,202 +781,698 13.95
    2026-01-15 6,319,202 6,213,363 +105,839 7.31
    2025-12-31 6,213,363 6,258,439 -45,076 8.35
    2025-12-15 6,258,439 6,677,161 -418,722 5.19
    2025-11-28 6,677,161 6,817,112 -139,951 7.16
    2025-11-14 6,817,112 6,424,987 +392,125 6.23
    2025-10-31 6,424,987 6,855,986 -430,999 6.08
    2025-10-15 6,855,986 7,640,225 -784,239 4.59

    Full FINRA short interest reporting calendar

    Showing 1–24 of 24 settlements
    Key facts CIK 1936258 CUSIP N62509109 13F (30d) 3 filings 3 filers Visit website Investor relations